Pesi, R.; Petrotto, E.; Colombaioni, L.; Allegrini, S.; Garcia-Gil, M.; Camici, M.; Jordheim, L.P.; Tozzi, M.G.
Cytosolic 5′-Nucleotidase II Silencing in a Human Lung Carcinoma Cell Line Opposes Cancer Phenotype with a Concomitant Increase in p53 Phosphorylation. Int. J. Mol. Sci. 2018, 19, 2115.
https://doi.org/10.3390/ijms19072115
AMA Style
Pesi R, Petrotto E, Colombaioni L, Allegrini S, Garcia-Gil M, Camici M, Jordheim LP, Tozzi MG.
Cytosolic 5′-Nucleotidase II Silencing in a Human Lung Carcinoma Cell Line Opposes Cancer Phenotype with a Concomitant Increase in p53 Phosphorylation. International Journal of Molecular Sciences. 2018; 19(7):2115.
https://doi.org/10.3390/ijms19072115
Chicago/Turabian Style
Pesi, Rossana, Edoardo Petrotto, Laura Colombaioni, Simone Allegrini, Mercedes Garcia-Gil, Marcella Camici, Lars Petter Jordheim, and Maria Grazia Tozzi.
2018. "Cytosolic 5′-Nucleotidase II Silencing in a Human Lung Carcinoma Cell Line Opposes Cancer Phenotype with a Concomitant Increase in p53 Phosphorylation" International Journal of Molecular Sciences 19, no. 7: 2115.
https://doi.org/10.3390/ijms19072115
APA Style
Pesi, R., Petrotto, E., Colombaioni, L., Allegrini, S., Garcia-Gil, M., Camici, M., Jordheim, L. P., & Tozzi, M. G.
(2018). Cytosolic 5′-Nucleotidase II Silencing in a Human Lung Carcinoma Cell Line Opposes Cancer Phenotype with a Concomitant Increase in p53 Phosphorylation. International Journal of Molecular Sciences, 19(7), 2115.
https://doi.org/10.3390/ijms19072115